[Neurotropic properties of aminooxyacetic acid and gamma-aminooxybutyric acid].
D000085:Acetates / Q000008:administration & dosage / Q000494:pharmacology*; D000613:Aminobutyrates / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry; D002087:Butyrates / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000037:antagonists & inhibitors*; D003864:Depression, Chemical; D004357:Drug Synergism; D004569:Electroencephalography; D051379:Mice; D009538:Nicotine / Q000037:antagonists & inhibitors*; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011817:Rabbits; D012663:Semicarbazides / Q000037:antagonists & inhibitors*; D012964:Sodium / Q000494:pharmacology*; D013035:Spasm / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control; D013268:Stimulation, Chemical; D013331:Strychnine / Q000037:antagonists & inhibitors; D013874:Thiopental / Q000494:pharmacology
D000085:Acetates; D000613:Aminobutyrates; D001463:Barbiturates; D002087:Butyrates; D000697:Central Nervous System Stimulants; D012663:Semicarbazides; D009538:Nicotine; D012964:Sodium; D013331:Strychnine; D013874:Thiopental; D010433:Pentylenetetrazole
O neirotropnykh svoistvakh aminooksiuksusnoi i gamma-aminooksikislot.